May 1997 Cryosurgical Publications

A weekly updated compilation of cryosurgery related publications

May 6thMay 13thMay 20thMay 27th
BIOSYS
MEDLINE

 

May 6th, 1997

BIOSYS Database:
1. Crawford FA Jr; Gillette PC.
     As originally published in 1989: Cryoablation of septal pathways in
     patients with supraventricular tachyarrhythmias. Updated in 1997.
   Annals of Thoracic Surgery, 1997 Apr, 63(4):1205-6.
     (UI:  97248359)

2. Sueda T; Nagata H; Orihashi K; Morita S; Okada K; Sueshiro M; Hirai S;
       Matsuura Y.
     Efficacy of a simple left atrial procedure for chronic atrial fibrillation
     in mitral valve operations.
   Annals of Thoracic Surgery, 1997 Apr, 63(4):1070-5.
       (UI:  97248321)

Abstract: BACKGROUND: We have devised a simple surgical procedure to be
    performed on the posterior wall of the left atrium for the treatment of
    chronic atrial fibrillation (AF) associated with mitral valve disease. The
    effectiveness of this procedure for serial mitral valve operations was then
    evaluated. We postulated that chronic AF associated with mitral valve
    disease could be attributable to a distended left atrium. The refractory
    period of the distended left atrium was significantly shorter in the left
    posterior atrial wall, especially at the base of the left atrial appendage
    and at the orifice of the left posterior pulmonary vein. We hypothesized
    that the left posterior atrial wall with its shorter fibrillatory cycle
    length would act as a driver for maintaining the AF, and therefore,
    surgical ablation of this critical area in the left atrium could terminate
    the chronic AF. METHODS: The surgical patients were divided into two
    groups. In group 1 (control group), 15 patients with chronic AF were
    operated on by the mitral valve procedure only. In group 2, 36 patients
    underwent this procedure in combination with a concomitant mitral valve
    operation. The disappearance rate of the AF was estimated by
    electrocardiography, and atrial function was estimated by transthoracic and
    transesophageal echocardiography. RESULTS: The chronic AF had been reduced
    significantly or eliminated at discharge in 4 of 15 patients (26.7%) in the
    group 1, versus 31 of 36 patients (86%) in group 2 (p < 0.05). In group 2,
    29 of the 31 patients (94%) whose AF had disappeared recovered the atrial
    kick of their right atrium, and 21 patients (22/31; 71%) recovered the
    atrial kick of their left atrium. CONCLUSIONS: Surgical ablation of the
    posterior wall of the left atrium was effective in the treatment of chronic
    AF associated with mitral valve disease. This simple procedure could
    restore a sinus rhythm and also recovered atrial systolic function. We
    conclude that the left atrium may act as a driver for sustaining AF in
    mitral valve disease.

3. Egbert JE; Kersten RC.
     Female genital tract papillomavirus in conjunctival papillomas of infancy.
   American Journal of Ophthalmology, 1997 Apr, 123(4):551-2.
       (UI:  97255158)

Abstract: PURPOSE: To show the association between conjunctival papillomas
    present during infancy and maternal infection with human papillomavirus.
    METHOD: Case report of conjunctival papillomas occurring in an infant born
    to a mother with a human papillomavirus infection of the vulva during
    pregnancy. RESULT: The infant developed conjunctival papillomas caused by
    human papillomavirus of the female genital tract. CONCLUSIONS: Conjunctival
    papillomas present during infancy may be caused by vertical transmission of
    the human papillomavirus from mother to infant during delivery. Mothers of
    infants with conjunctival papillomas should be examined for diseases
    associated with human papillomavirus.

4. Johnson LB; Krebs T; Wong-You-Cheong J; Njoku M; Plotkin JS; Daly B; Wilson
       S; Kuo PC.
     Cryosurgical debulking of unresectable liver metastases for palliation of
     carcinoid syndrome.
   Surgery, 1997 Apr, 121(4):468-70.
     (UI:  97250952)

5. Carroll PR; Presti JC Jr; Small E; Roach M 3rd.
     Focal therapy for prostate cancer 1996: maximizing outcome.
   Urology, 1997 Mar, 49(3A Suppl):84-94.
     Pub type:  Journal Article; Review; Review, Tutorial.
       (UI:  97237005)

Abstract: OBJECTIVES: To summarize improvements in patient selection and the
    results of focal therapy for the management of localized prostate cancer.
    METHODS: A contemporary series of patients managed with wide surgical
    excision, radiation therapy (three-dimensional conformal radiation,
    interstitial radiation, and charged-particle or proton therapy), and
    cryo-therapy were reviewed. RESULTS: We used preoperative cancer grade,
    transrectal ultrasound, and serum prostate-specific antigen (PSA) in all
    patients, and cross-sectional imaging and bone scans in selected patients
    to allow for reasonably accurate cancer staging and selection of patients
    most likely to be cured by radical prostatectomy or radiation. In patients
    with extracapsular extension of prostate cancer, wide surgical excision and
    achievement of a clear surgical margin had therapeutic value. Newer
    radiation techniques resulted in a higher likelihood of prostate cancer
    control than previous techniques. Cryotherapy for patients with stages T1
    through 3 prostate cancer was associated with a posttreatment undetectable
    PSA rate of 48% and a positive biopsy rate of 23%. CONCLUSIONS: Patients
    with organ-confined and, therefore, curable prostate cancer can be
    identified. Well-performed radical prostatectomy, radiation, and
    cryotherapy are alternative treatments for the management of localized
    prostate cancer.

6. Koushafar H; Rubinsky B.
     Effect of antifreeze proteins on frozen primary prostatic adenocarcinoma
     cells.
   Urology, 1997 Mar, 49(3):421-5.
       (UI:  97225838)

Abstract: OBJECTIVES: Recent studies show that prostate adenocarcinoma cells
    can survive cryosurgery and that cell destruction depends on the specific
    thermal parameters used during freezing. The goal of this preliminary study
    is to determine whether certain chemical compounds, known as antifreeze
    proteins, can induce complete human primary prostatic adenocarcinoma cell
    destruction by freezing, regardless of the thermal parameters used. The
    study also examines the mechanism by which antifreeze proteins bring about
    cell destruction. METHODS: Antifreeze proteins were added to solutions
    containing human primary prostatic adenocarcinoma cells. The cells were
    frozen with controlled thermal parameters using a directional
    solidification apparatus attached to a light microscope. Cell viability was
    determined after thawing as a function of antifreeze protein concentration
    and cooling rate during freezing. RESULTS: The dose response study shows
    that for all the cooling rates tested, 10-mg/mL solutions of antifreeze
    protein cause the complete destruction of human primary prostatic
    adenocarcinoma cells frozen to a temperature at which, without these
    proteins, the cells survive freezing. Light microscopy shows that the
    lethal effect of the antifreeze proteins is related to the formation of
    intracellular ice in the frozen cells. CONCLUSIONS; This preliminary study
    has demonstrated that antifreeze proteins have the ability to generate
    complete destruction of prostatic adenocarcinoma cells frozen to high
    subzero temperatures irrespective of the cooling rates used during
    freezing. This suggests that introducing antifreeze proteins into
    undesirable tissues prior to freezing may increase the efficacy and the
    control over tissue destruction by cryosurgery.

7. Eckhauser FE; Knol JA.
     Surgery for primary and metastatic colorectal cancer.
   Gastroenterology Clinics of North America, 1997 Mar, 26(1):103-28.
     Pub type:  Journal Article; Review; Review, Tutorial.
       (UI:  97187349)

Abstract: Carcinoma of the colon and rectum currently ranks as the second
    leading cause of death from cancer in the United States. Surgery remains
    the cornerstone of treatment for colorectal cancer but has inherent
    limitations imposed by the biology and stage of the tumor and its location.
    Ultimately, 50% of patients who undergo curative resection develop local,
    regional, or widespread recurrence. These statistics have remained
    relatively constant over several decades despite improved methods of early
    diagnosis and surgical treatment but may change as new multimodality
    treatment regimens are developed and clinically evaluated. This article
    summarizes the surgical management of colorectal cancer and discusses
    issues pertaining to postoperative surveillance and the diagnosis and
    management of local or widespread cancer recurrence.

  

May 6th, 1997

MedLine Database:
(none)

May 13th, 1997

BIOSYS Database:
1. Descamps, V; Aractingi, S; Venencie, P-Y.
     Cutaneous carcinomas.
     Annales de Dermatologie et de Venereologie, v.124, n.1, (1997): 12-29.
     Language:  French.

2. Koushafar, H; Rubinsky, B.
     Effect of antifreeze proteins on frozen primary prostatic adenocarcinoma
   cells.
     Urology, v.49, n.3, (1997): 421-425.

Abstract:
     Objectives. Recent studies show that prostate adenocarcinoma cells can
     survive cryosurgery and that cell destruction depends on the specific
     thermal parameters used during freezing. The goal of this preliminary
     study is to determine whether certain chemical compounds, known as
     antifreeze proteins, can induce complete human primary prostatic
     adenocarcinoma cell destruction by freezing, regardless of the thermal
     parameters used. The study also examines the mechanism by which antifreeze
     proteins bring about cell destruction. Methods. Antifreeze proteins were
     added to solutions containing human primary prostatic adenocarcinoma
     cells. The cells were frozen with controlled thermal parameters using a
     directional solidification apparatus attached to a light microscope. Cell
     viability was determined after thawing as a function of antifreeze protein
     concentration and cooling rate during freezing. Results. The dose response
     study shows that for all the cooling rates tested, 10-mg/mL solutions of
     antifreeze protein cause the complete destruction of human primary
     prostatic adenocarcinoma cells frozen to a temperature at which, without
     these proteins, the cells survive freezing. Light microscopy shows that
     the lethal effect of the antifreeze proteins is related to the formation
     of intracellular ice in the frozen cells. Conclusions. This preliminary
     study has demonstrated that antifreeze proteins have the ability to
     generate complete destruction of prostatic adenocarcinoma cells frozen to
     high subzero temperatures irrespective of the cooling rates used during
     freezing. This suggests that introducing antifreeze proteins into
     undesirable tissues prior to freezing may increase the efficacy and the
     control over tissue destruction by cryosurgery.

3. Cohen, J K; Miller, R J Jr; Rooker, G M; Benoit, R; Merlotti, L.
     Four year PSA and biopsy results after cryosurgical ablation of the
   prostate (CSAP) for localized adenocarcinoma of the prostate. (92nd Annual
   Meeting of the American Urological Association, New Orleans, Louisiana,...
     Journal of Urology, v.157, n.4 SUPPL., (1997): 419.

4. Nakada, S Y; Lee, F T Jr; Warner, T; Chosy, S G; Moon, T D.
     Laparoscopic cryosurgery of the kidney in swine: A comparison of puncture
   and contact techniques. (92nd Annual Meeting of the American Urological
   Association, New Orleans, Louisiana, USA, April 12-17, 1997. )
     Journal of Urology, v.157, n.4 SUPPL., (1997): 401.

5. McLoughlin, R F; Chin, J L; Downey, D B.
     3-Dimensional transrectal ultrasound (3-D TRUS) appearance of pelvic
   anatomy relevant to cryoablation of the prostate (CAbP). (92nd Annual
   Meeting of the American Urological Association, New Orleans, Louisiana,...
     Journal of Urology, v.157, n.4 SUPPL., (1997): 323.

6. Fernandez, A Z; Leal, J J.
     Incontinence following cryoablation of prostatic carcinoma in radiation
   treatment failure patients: The need for cryosurgical probes of various
   length. (92nd Annual Meeting of the American Urological Association,...
     Journal of Urology, v.157, n.4 SUPPL., (1997): 292.

7. Cozzi, P J; Lynch, W J.
     Experimental and clinical observations of urethral warming catheters for
   transperineal cryosurgery of localised prostate cancer: Low morbidity is
   achievable. (92nd Annual Meeting of the American Urological Association,...
     Journal of Urology, v.157, n.4 SUPPL., (1997): 289.

8. Long, J P; Fallick, M L; Rand, W.
     Cryoablation (CP) for patients with T1-T3 PCA. (92nd Annual Meeting of the
   American Urological Association, New Orleans, Louisiana, USA, April 12-17,
   1997. )
     Journal of Urology, v.157, n.4 SUPPL., (1997): 288.

9. Miller, R J Jr; Cohen, J K; Rooker, G M; Benoit, R.
     External beam radiation (XRT) as salvage therapy for biopsy failure after
   cryosurgical ablation of the prostate (CSAP). (92nd Annual Meeting of the
   American Urological Association, New Orleans, Louisiana, USA, April...
     Journal of Urology, v.157, n.4 SUPPL., (1997): 252.

10. Chosy, S G; Nakada, S Y; Lee, F T Jr; Warner, T.
      Thermosensor-monitored renal cryosurgery in swine: Predictors of tissue
    necrosis. (92nd Annual Meeting of the American Urological Association, New
    Orleans, Louisiana, USA, April 12-17, 1997. )
      Journal of Urology, v.157, n.4 SUPPL., (1997): 250.

11. Kohn, I J; Seidmon, E J; Hanno, P M; Pontari, M A.
      Voiding dysfunction following cryosurgery of the prostate. (92nd Annual
    Meeting of the American Urological Association, New Orleans, Louisiana,
    USA, April 12-17, 1997. )
      Journal of Urology, v.157, n.4 SUPPL., (1997): 184.

12. Chin, J L; Downey, D B; Fenster, A.
      Cryoablation for prostate cancer: Detailed depiction of a new cryogenic
    system with 3-dimensional ultrasound guidance. (92nd Annual Meeting of the
    American Urological Association, New Orleans, Louisiana, USA, April...
      Journal of Urology, v.157, n.4 SUPPL., (1997): 158.

13. Benoit, R M; Miller, R J Jr; Cohen, J K.
      Comparison of hospital costs for radical prostatectomy and cryosurgical
    ablation of the prostate. (92nd Annual Meeting of the American Urological
    Association, New Orleans, Louisiana, USA, April 12-17, 1997. )
      Journal of Urology, v.157, n.4 SUPPL., (1997): 155.

14. Rhee, B; Shinohara, K; Presti, J C Jr; Carroll, P R.
      The pattern of relapse after cryosurgical ablation of prostate cancer.
    (92nd Annual Meeting of the American Urological Association, New Orleans,
    Louisiana, USA, April 12-17, 1997. )
      Journal of Urology, v.157, n.4 SUPPL., (1997): 94.

15. Linaers, M; Sanchez Conejo-Mir, J; Artola, J L; Corbi, M R; Jimenez, G;
    Navarrete, M.
      Alpha 1-antitrypsin deficiency panniculitis provoked by cryosurgery.
    (34th Annual Meeting of the American Society of Dermatopathology, San
    Francisco, California, USA, March 18-20, 1997. )
      Journal of Cutaneous Pathology, v.24, n.2, (1997): 109.

  

May 13th, 1997

MedLine Database:
1. Benito Bartolome F; Sanchez Fernandez-Bernal C; Jimenez Casso S.
     [Congenital ectopic junctional tachycardia: long-term remission after
     cryoablation of the bundle of His].
   Revista Espanola de Cardiologia, 1997 Mar, 50(3):211-3.
     Language:  Spanish.
       (UI:  97243241)

Abstract: Congenital junctional ectopic tachycardia is an uncommon and
    potentially fatal arrhythmia that does not usually respond to medical
    therapy. We report a two month old infant with severe ventricular failure.
    The diagnosis was confirmed by electrophysiologic study. She underwent
    endocardial cryoablation of the His bundle during extracorporeal
    circulation and a ventricle epicardial-lead pacemaker was implanted. Eight
    years later the patient is still symptom-free without needing medical
    treatment.

2. Coleman WP 3rd.
     Advances in dermatologic surgery [editorial].
   Dermatologic Surgery, 1997 Feb, 23(2):78-82.
     Pub type:  Editorial.
     (UI:  97261327)

3. Dufresne RG Jr; Curlin MU.
     Actinic cheilitis. A treatment review.
   Dermatologic Surgery, 1997 Jan, 23(1):15-21.
     Pub type:  Journal Article; Review; Review, Tutorial.
       (UI:  97261335)

Abstract: BACKGROUND: Actinic cheilitis is a common premalignant condition,
    significant for symptoms and potential development into invasive squamous
    cell carcinoma. Multiple methods of treatment have been reported for this
    entity. OBJECTIVE: The purpose of this article is to review and compare the
    accepted treatment modalities reported for actinic cheilitis. METHODS: The
    English language literature was reviewed for treatment options, efficacy
    and adverse effects. RESULTS: Cryosurgery, electrocautery, 5-fluorouracil,
    carbon dioxide laser, and scalpel vermilionectomy were all clinically
    effective. All therapies, with the exception of chemical peeling, appear to
    have a low clinical failure rate. Histological clearance of disease was
    demonstrated in carbon dioxide laser-treated patients. 5-Fluorouracil
    failed to achieve complete removal of histologic dysplasia. The carbon
    dioxide laser may be associated with less scarring and an improved cosmetic
    outcome in comparison with the scalpel vermilionectomy. CONCLUSION: Focal
    actinic cheilitis is easily treated with cryosurgery or electrosurgery.
    Extensive actinic cheilitis requires 5-fluorouracil, carbon dioxide laser,
    or scalpel vermilionectomy for adequate treatment. The carbon dioxide laser
    offers some advantages over scalpel vermilionectomy.

May 20th, 1997

BIOSYS Database:

(none) 

May 20th, 1997

MedLine Database:
1. Zucker I; Charkes ND; Seidmon EJ; Maurer AH.
     Soft-tissue uptake of technetium-99m-MDP after prostate cryoablation.
   Journal of Nuclear Medicine, 1997 Apr, 38(4):525-8.
       (UI:  97252737)

Abstract: Prominent soft-tissue uptake of 99mTc-methylene diphosphonate (MDP)
    within the prostate bed was found after cryoablation for prostate
    carcinoma. CT, MRI and sonographic studies demonstrated liquifactive
    necrosis of the prostate bed. The probable etiology for 99mTc-MDP uptake in
    this case is necrosis with subsequent neovascular hyperemia and microscopic
    calcium deposits. Three-phase scintigraphy with 99mTc-MDP appears to be
    useful for localizing the extent of soft tissue inflammation and necrosis.

2. Geyer O; Michaeli-Cohen A; Silver DM; Neudorfer M; Lazar M.
     The mechanism of intraocular pressure rise during cyclocryotherapy.
   Investigative Ophthalmology and Visual Science, 1997 Apr, 38(5):1012-7.
       (UI:  97267667)

Abstract: PURPOSE: Intraocular pressure (IOP) spikes that occur during
    cyclocryotherapy for advanced glaucoma may further injure the already
    damaged glaucomatous optic nerve and be responsible for visual impairment
    that may occur after this treatment. The authors investigated the mechanism
    of pressure rise to see whether it can be avoided and thus prevent further
    optic nerve injury. The authors postulated that intraocular ice forms
    during the cryo procedure and causes the pressure changes. METHODS:
    Intraocular pressure was monitored using a pneumatonometer during 15
    cryocycles of four patients with advanced glaucoma and 21 cryocycles of
    five normal rabbits. A simple thermal model was developed to analyze the
    relation between volume expansion and pressure rise in the eye. The
    physical effect of freezing rabbit eye structures was investigated in
    vitro. RESULTS: The largest pressure spikes observed during the cryocycles
    in this work were increases of 32 mm Hg for humans and 25 mm Hg for
    rabbits. The mean value of the IOP immediately before and after the cryo
    freezing stage was 53 +/- 1 and 68 +/- 2 mm Hg, respectively, for humans
    and 22 +/- 1 and 32 +/- 1 mm Hg for rabbits. The parameters of the thermal
    model were determined from the observed IOP spikes. Calculated thaw times
    were consistent with measured times for return to precryo IOPs. In vitro
    cryoapplication (rabbit eye) showed the formation of an ice ball internal
    to the eye. CONCLUSIONS: Volumetric increase of the intraocular content
    related to the formation of an ice ball in the eye, is the mechanism of
    pressure spikes during cyclocryotherapy. Because this complication is
    unavoidable, other cyclodestuctive methods may be more prudent,
    particularly in patients with advanced glaucoma.

  

May 27th, 1997

BIOSYS Database:

(none) 

May 27th, 1997

MedLine Database:
1. Connolly JA; Shinohara K; Presti JC Jr; Carroll PR.
     Prostate-specific antigen after cryosurgical ablation of the prostate.
     Defining the appropriate response.
   Urologic Clinics of North America, 1997 May, 24(2):415-20.
       (UI:  97271288)

Abstract: The ability of prostate-specific antigen (PSA) to predict long-term
    cure after cryotherapy for localized prostate cancer is not known because
    experience with this treatment modality is limited; however, it appears
    that a PSA value of 0.5 ng/mL or less at 6 months or longer after
    cryotherapy is associated with a high probability of a negative
    post-treatment biopsy (greater than 95%). An undetectable PSA (less than
    0.1 ng/mL) 3 months after the procedure is associated with a likelihood of
    a negative biopsy at 6 months and low, stable PSA levels up to 2 years.

2. Leow CK; Lau WY.
     Cryosurgery for malignant hepatic tumours [letter].
   Canadian Journal of Surgery, 1997 Apr, 40(2):151.
     Pub type:  Letter.
     (UI:  97271183)

3. Khait O; Zaporozhan V.
     The effectiveness of cryoendoscopic treatment for tubal infertility.
   Journal of the American Association of Gynecologic Laparoscopists, 1995 Feb,
   2(2):187-91.
       (UI:  97203386)

Abstract: Seventy-three women experienced bilateral proximal tubal occlusion
    caused by adhesions or polyps arising from the uterotubal junction in at
    least one tube. There were no other identifiable causes of infertility. All
    patients were treated with cryosurgery, which restored tubal patency in 61
    (83.6%). Of 45 women with restored patency, who were followed 6 to 12
    months, 20 (27.4% of 73) conceived and 16 (21.9%) delivered viable babies.